title: Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant.
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital , Osaka , Japan.
authors.forename: Mitsumasa
authors.initials: M
authors.lastname: Watanabe
authors.forename: Chishiho
authors.initials: C
authors.lastname: Nakamura
authors.forename: Sumie
authors.initials: S
authors.lastname: Fujii
authors.forename: Hitomi
authors.initials: H
authors.lastname: Kaneko
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Hirata
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Tsudo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D014184:Transplantation, Homologous